Janney Montgomery Scott Llc invested in 10,000 shares. 9 funds opened positions while 16 raised stakes. AntaresPharma, Inc. (ATRS) stock moved with shift of -0.32% in the past week. Its book value per share for the most …
Antares Pharma (ATRS) stock is decreasing on Tuesday morning after the company reported its 2015 fourth quarter …
The stock has an average rating of “Buy” and an average price target of $3.83. Get Antares Pharma Inc. alerts: Shares of Antares Pharma (NASDAQ ATRS) traded up 2.09% during trading on Wednesday, hitting $2.93. 1,188,761 shares of …
Jw Asset Management Llc acquired 252,205 shares as Antares Pharma Inc (ATRS)'s stock 0.00%. Stock analysts expect that Antares Pharma, to post ($0.13) EPS for the full year. 05/14/2015 - Antares Pharma, Inc. was upgraded to "hold" …
Chaim Katzman is the founder, controlling shareholder and Chairman of Gazit-Globe, a leading international real estate company listed on the Tel Aviv Stock Exchange (TASE: GZT) and the New York Stock Exchange (NYSE: GZT) and the …
The firm's market cap is $479.47 million. The stock decreased 0.36% or GBX 0.15 on August 7, reaching GBX 42.1. Goldman Sachs Group Inc. raised its stake in Antares Pharma Inc (NASDAQ:ATRS) by 338.0% during the first quarter, …
The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that ATRS stock has a topline or revenue of $52.22M for 2016 as per this Antares Pharma revenue chart. …
The stock Hit its 1-year high of $3.24 on 04/26/17 and its 1-year low price of $0.92 on 06/24/16. Schwab Charles Management stated it has 0% of its portfolio in Antares Pharma Inc (NASDAQ:ATRS). Geode Cap Mngmt Lc invested …
Stating a potential upside of 0.51%, Raymond James Financial upped the price target of Antares Pharma ATRS